📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-09 19:56
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
33 announcements match the current filters (relevance ≥ 5).
Emami Closes ₹281.24 Cr Buyback After Repurchasing 73 Lakh Shares
Emami Limited has closed its open-market share buyback on October 9, 2026, deploying ₹281.24 crore (99.73% of the maximum authorized size of ₹282 crore). The company bought back 73,00,000 equity shares at an average price of ₹385.26 per share, against a ceiling price of ₹475. Following extinguishment, the total equity share base decreases from 43.65 crore to 42.92 crore shares. Consequently, promoter holding increases from 54.84% to 55.78%.
Confidence: HIGH
What changedEmami completed and formally closed its open-market buyback program with 99.73% fund deployment.
Why it mattersThe reduction of 73 lakh shares (~1.67% of equity base) will provide a modest accretion to future EPS and return ratios while returning surplus cash to shareholders.
Total Amount Deployed: ₹ 2,81,24,10,607.90Shares Bought Back: 73,00,000Average Buyback Price: ₹ 385.26Utilization of Max Buyback Size: 99.73%Buyback Size vs Market Cap: ~1.74%
📅 Short termRemoves direct daily price support from company buying in the open market, as the program closed ahead of the 66-day window.
📈 Long termLimited operational impact; slightly enhances EPS and ROCE due to reduced equity capital and deployment of surplus cash reserves.
Key Highlights
Deployed ₹281.24 crore out of the ₹282.00 crore maximum buyback size (99.73% utilization)
Repurchased 73,00,000 equity shares at an average price of ₹385.26 per share
Total share base reduced by 1.67% from 43,65,00,000 to 42,92,00,000 shares
Promoter group shareholding increases from 54.84% to 55.78% post-extinguishment
👀 What to Watch
Track the upcoming post-buyback public advertisement and confirmation of share extinguishment, followed by the impact on reported EPS in Q2/Q3 FY27 results.
Emami Announces ₹282 Cr Share Buyback at Up to ₹475/Share via Open Market
Emami Limited has released its public announcement for an open market share buyback through stock exchanges, following board approval on September 17, 2026. The company plans to deploy up to ₹28,200 Lakhs (₹282 Cr) at a maximum price of ₹475 per share, representing a ~29% premium over its current market price of ₹368.4. The buyback size represents approximately 1.75% of the company's market cap of ₹16,108 Cr and 8.9% of its net worth (₹3,156 Cr). Promoters and promoter group entities are excluded from participating.
Confidence: HIGH
What changedFormal public announcement issued detailing the execution framework and terms for Emami's open market share buyback approved on September 17, 2026.
Why it mattersUtilizes ₹282 Cr of surplus cash to reduce the equity base, supporting EPS and return ratios while offering downside price support via exchange purchases.
Maximum Buyback Size: ₹ 28,200.00 LakhsMaximum Buyback Price: ₹475.00/-Face Value per Share: ₹ 1/-Buyback size vs Market Cap: ~1.75%Buyback size vs Net Worth: ~8.9%
📅 Short termOpen market buying by the company at prices up to ₹475 per share is likely to provide liquidity and support the stock price near-term.
📈 Long termReduces outstanding share count, modestly enhancing EPS and ROCE, reflecting ongoing disciplined capital return.
⚠ Risk flags
- Open market route does not guarantee deployment of the full ₹282 Cr if market prices exceed ₹475
Key Highlights
Maximum buyback size capped at ₹28,200.00 Lakhs (₹282 Cr)
Maximum buyback price set at ₹475.00 per share
Conducted via open market route through stock exchange mechanism
IIFL Capital Services Limited appointed as Manager to the Buyback
Promoters and promoter group are barred from participating or trading during the buyback
👀 What to Watch
Track daily buyback exchange disclosures to monitor absorption rate and the actual average purchase price relative to the ₹475 ceiling.
Emami Approves ₹282 Cr Share Buyback at up to ₹475/Share via Open Market
Emami Limited's Board has approved an open-market share buyback for an aggregate amount not exceeding ₹282.00 crore (₹28,200 lakh) at a maximum price of ₹475.00 per share. The maximum buyback price represents a 23.1% premium over the current market price of ₹385.9. The indicative maximum number of shares to be repurchased is 59,36,842, representing approximately 1.36% of the company's total paid-up equity share capital. The total buyback size constitutes 9.98% of the company's net worth and 1.67% of its market capitalization.
Confidence: HIGH
What changedThe Board approved an open-market equity share buyback of up to ₹282 crore at a ceiling price of ₹475 per share.
Why it mattersThe buyback signals capital return to shareholders at a 23% premium over market price, effectively shrinking share count by up to 1.36% and slightly expanding future EPS and promoter ownership.
Maximum Buyback Size: ₹28,200.00 LakhsMaximum Buyback Price: ₹475.00 per Equity ShareMaximum Buyback Shares: 59,36,842Equity Capital Represented: 1.36%Minimum Buyback Size: ₹21,150.00 LakhsBuyback Size vs Market Cap: ~1.67%
📅 Short termThe ceiling price of ₹475 provides near-term downside support to the stock price as the company begins buying shares from the open market.
📈 Long termLimited; while it demonstrates efficient capital allocation with minimal debt (D/E of 0.03), a 1.36% equity reduction is an incremental rather than transformational EPS driver.
⚠ Risk flags
- Open market route means actual purchase prices will depend on market rates and may not reach the ceiling price of ₹475
- Promoters cannot participate, reducing public float moderately
Key Highlights
Maximum buyback size of up to ₹28,200.00 Lakhs (₹282 Cr) at a maximum price of ₹475.00 per equity share
Proposed repurchase of up to 59,36,842 shares, representing 1.36% of paid-up equity capital
Buyback route is open market via stock exchange mechanism (promoters will not participate)
Minimum utilization set at 75% of maximum size (₹21,150.00 Lakhs), with at least 40% (₹11,280.00 Lakhs) deployed in the first half of the offer
Promoter shareholding will increase from 54.84% to 55.60% post-buyback at maximum shares
👀 What to Watch
Track the upcoming public announcement for the exact opening date, closure date, and operational timelines of the open-market buyback offer.
15% Revenue Growth in Q1 FY27; Strategic Digital Portfolio Surges 61%
Emami Limited reported a 15% YoY increase in consolidated revenue to ₹1,039 cr for Q1 FY27, supported by a 20% growth in the domestic business. While core domestic volume grew by 8%, the strategic investment portfolio (including The Man Company and Brillare) grew by 61% and now contributes 18% of domestic revenue. Profitability faced headwinds from higher input costs and a normalized tax rate, resulting in a 16% decline in PAT to ₹137 cr. The international business saw a 12% decline, primarily due to geopolitical disruptions in West Asia.
Confidence: HIGH
What changedThe company has transitioned to category-wise reporting and integrated new acquisitions (Axiom and IncNut), shifting its mix toward digital-first brands.
Why it mattersThe rapid scaling of the strategic portfolio (18% of domestic) reduces dependence on legacy brands, though it currently comes with higher COGS and margin pressure.
Q1 Consolidated Revenue: ₹1,039 crDomestic Volume Growth (LTL): 8%Axiom Investment vs Net Worth: ~15.8%EBITDA Growth: 6%Expected FY27 Tax Rate: 25-26%
📅 Short termThe stock may face pressure due to the 16% PAT decline and international headwinds, despite healthy domestic volume growth.
📈 Long termStructural shift toward premium grooming and digital channels (32% of domestic) provides a new growth runway, though margin management remains critical.
⚠ Risk flags
- Geopolitical instability in West Asia and Bangladesh
- Inflation in crude oil and packaging materials
- Higher effective tax rate compared to previous years
Key Highlights
Consolidated revenue grew 15% YoY to ₹1,039 cr, with domestic like-to-like volume growth at 8%.
Strategic investment portfolio grew 61% like-to-like, now representing 18% of domestic business.
International business declined by 12% due to West Asia conflict constraints.
Axiom Ayurveda acquisition involved an investment of approximately ₹500 cr, funded through internal accruals.
Quick commerce now contributes 35% of the company's total e-commerce business.
👀 What to Watch
Investors should monitor the recovery of the international segment and the effectiveness of planned price increases in offsetting raw material inflation (crude and packaging).
15% Revenue Growth in Q1FY27; Domestic Volumes Up 8% Amid Margin Pressure
Emami Limited reported a 15% YoY increase in consolidated revenue to ₹1,039.2 crore for Q1FY27, supported by a 20% growth in domestic business. However, gross margins contracted by 360 bps to 65.8% due to elevated crude and packaging costs, resulting in a modest 6% EBITDA growth of ₹226.2 crore. Net profit declined 15.4% to ₹138.9 crore, primarily due to a significant 147% increase in tax expenses. The strategic investment portfolio (Axiom, IncNut) was a highlight, growing 61% on a like-to-like basis and now contributing 18% to domestic sales.
Confidence: HIGH
What changedThe company has transitioned to category-led reporting and fully consolidated recent acquisitions Axiom Ayurveda and IncNut Digital.
Why it mattersThe results demonstrate strong volume-led growth in the domestic market and successful scaling of new-age brands, though profitability is temporarily impacted by macro headwinds and higher taxes.
Q1 Revenue: ₹1,039.2 CrQ1 Revenue vs TTM Revenue: 27.5%Gross Margin: 65.8%Domestic Volume Growth (LFL): 8%EBITDA Growth: 6%Tax Expense Growth: 147.7%
📅 Short termThe stock may face pressure due to the 15.4% decline in PAT and margin contraction, despite the healthy topline performance.
📈 Long termStructural shift towards digital-first brands and organized trade (32% share) reduces reliance on traditional wholesale and seasonal legacy products.
⚠ Risk flags
- Geopolitical instability in West Asia impacting international revenue
- Volatility in crude oil prices affecting packaging and input costs
- Sharp increase in effective tax rate
Key Highlights
Consolidated revenue reached ₹1,039.2 crore, representing approximately 27% of TTM revenue.
Domestic like-to-like volume growth stood at 8%, while reported domestic value growth was 20%.
Gross margins contracted by 360 basis points to 65.8% due to inflationary pressures in crude and packaging.
International business declined by 12% YoY, impacted by disruptions from the West Asia conflict.
Organised channels (E-commerce and Modern Trade) now contribute 32% of domestic business, growing 19% YoY.
👀 What to Watch
Monitor the stabilization of input costs (crude derivatives) and the recovery of the international segment, which currently faces geopolitical headwinds in West Asia.
15% Revenue Growth in Q1 FY27; Domestic Business Up 20% Amid Margin Pressure
Emami reported a 15% YoY increase in consolidated revenue to ₹1,039 crore for Q1 FY27, driven by a 20% surge in domestic business. However, gross margins contracted by 360 bps to 65.8% due to elevated crude and packaging costs, resulting in a modest 6% EBITDA growth of ₹226 crore. The international business faced a 12% decline due to West Asia disruptions, while strategic investments (Axiom, IncNut) now contribute 18% of domestic sales. Despite a 4% PBT growth, PAT fell 15.4% YoY to ₹138.9 crore, primarily due to a sharp increase in tax expenses.
Confidence: HIGH
What changedEmami has transitioned to category-led reporting and fully consolidated Axiom Ayurveda and IncNut Digital, which significantly boosted domestic revenue figures.
Why it mattersThe results demonstrate strong domestic volume resilience (8% LTL) but highlight vulnerability to global commodity prices and geopolitical risks in international markets.
Revenue (Q1 FY27): ₹1,039.2 crEBITDA Growth: 6%Gross Margin: 65.8%Strategic Portfolio Contribution: 18% of domestic businessInternational Revenue Change: -12%PAT (Q1 FY27): ₹138.9 cr
📅 Short termThe market may focus on the 360 bps margin contraction and the 15% PAT decline, which could offset the positive sentiment from strong domestic topline growth.
📈 Long termThe structural shift toward organized channels (32% of domestic) and digital-first brands suggests a successful pivot toward modern retail and younger demographics.
⚠ Risk flags
- Geopolitical instability in West Asia impacting international sales
- Input cost inflation (crude oil and packaging)
- Significant increase in tax expense impacting bottom-line growth
Key Highlights
Consolidated revenue grew 15% YoY to ₹1,039 crore, representing ~27% of TTM revenue.
Domestic volume growth stood at 8% on a like-to-like basis, excluding recent acquisitions.
Gross margins contracted by 360 basis points to 65.8% due to input cost inflation in crude and packaging.
Strategic investments portfolio (Axiom, IncNut) grew 61% like-to-like, now contributing 18% of domestic revenue.
International business revenue declined by 12% due to geopolitical conflicts in West Asia.
👀 What to Watch
Monitor the recovery in international markets and the stabilization of input costs (crude/packaging) to see if margins return to the historical 25-26% OPM range. Watch for the continued scaling of digital-first brands like The Man Company and Vedix.
Emami Ltd Approves Q1 FY27 Financial Results for Quarter Ended June 30, 2026
Emami Limited's Board of Directors met on August 4, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This routine quarterly filing marks the first performance update for the new fiscal year. Based on previous context, the company enters this period with a TTM revenue of Rs 3,779 Cr and a healthy OPM of 25.5%. Investors should focus on volume growth and the performance of digital-first brands which recently reached a 12% e-commerce contribution.
Confidence: HIGH
What changedThe company has formally approved and released its financial performance data for the April-June 2026 quarter.
Why it mattersAs a leader in niche personal care categories, these results indicate the success of Emami's volume-led strategy and its ability to penetrate rural markets amidst inflationary pressures.
TTM Revenue: Rs 3779 CrTTM PAT: Rs 775 CrMarket Cap: Rs 17520 CrOperating Profit Margin: 25.5%Debt to Equity: 0.03
📅 Short termThe stock may see volatility in the coming days as the market digests the specific revenue and margin figures relative to analyst expectations.
📈 Long termStructural growth depends on the scaling of digital-first brands (Brillare, TMC) and the recovery of international markets like Bangladesh.
⚠ Risk flags
- Geopolitical instability in Bangladesh affecting international revenue
- Volatility in global commodity prices impacting gross margins
Key Highlights
Board approved unaudited financial results for the quarter ended June 30, 2026
TTM Revenue stands at Rs 3,779 Cr with a TTM PAT of Rs 775 Cr
Company maintains a strong ROCE of 30.0% and low Debt/Equity of 0.03
E-commerce now contributes 12% to domestic business, up from single digits
Board meeting concluded within 95 minutes (12:00 PM to 1:35 PM)
👀 What to Watch
Review the detailed P&L for volume growth in core categories like cooling oils and antiseptic creams, and monitor if gross margins (previously 68.6%) are sustained despite commodity price trends.
Emami Increases Stake in IncNut Digital to 60.00% Following Share Acquisition
Emami Limited has acquired an additional 1,064 equity shares in IncNut Digital Private Limited on June 11, 2026. This transaction has increased Emami's total shareholding in the company from 59.69% to 60.00%. The acquisition was completed as per the terms of a previously disclosed Share Subscription and Purchase Agreement. This move further consolidates Emami's controlling interest in the digital-first beauty and wellness platform.
Key Highlights
Acquired 1,064 equity shares of IncNut Digital Private Limited on June 11, 2026.
Total stake in IncNut Digital increased from 59.69% to 60.00%.
The acquisition follows the terms of the Share Subscription and Purchase Agreement dated May 7, 2026.
Consolidates Emami's presence in the digital media and e-commerce beauty segment.
👀 What to Watch
No immediate action is required as this is a marginal 0.31% increase in stake within an existing subsidiary. Investors should monitor how Emami leverages IncNut's digital capabilities to drive growth in its D2C portfolio.
Emami Completes Acquisition of 59.69% Stake in IncNut Digital
Emami Limited has successfully completed the acquisition of 2,05,767 equity shares in IncNut Digital Private Limited, representing a 59.69% stake. As of June 1, 2026, IncNut has officially become a subsidiary of Emami. The company further intends to acquire the remaining 0.31% stake (1,064 shares) as per the existing Share Subscription and Purchase Agreement. This move is part of Emami's broader strategy to enhance its presence in the digital and D2C ecosystem.
Key Highlights
Acquired 59.69% controlling stake consisting of 2,05,767 equity shares
IncNut Digital Private Limited has officially become a subsidiary of Emami Limited
Remaining 0.31% stake (1,064 shares) to be acquired as per the purchase agreement
Transaction completed on June 1, 2026, following the initial May 7, 2026 announcement
👀 What to Watch
Investors should monitor the integration of IncNut's digital capabilities into Emami's portfolio and its impact on the company's e-commerce growth trajectory. This acquisition strengthens Emami's positioning in the high-growth D2C segment.
Emami Q4 FY26: Revenue Dips 4% Due to Weak Summer; Non-Summer Portfolio Grows 11%
Emami reported a 4% YoY revenue decline to INR 925 crores in Q4 FY26, heavily impacted by a 22% drop in the summer portfolio due to unseasonal weather. However, the core non-summer domestic business grew 11%, and gross margins expanded significantly by 250 bps to 68.4%. International operations fell 5% due to Middle East supply chain disruptions, but management anticipates a rebound to double-digit growth by Q2 FY27. The company is focusing on high-growth channels like Quick Commerce, which surged 70% during the quarter.
Key Highlights
Gross margins expanded 250 bps to 68.4% despite a 4% decline in consolidated revenue to INR 925 crores.
Summer portfolio (Talcum, etc.) fell 22%, while Kesh King and Pain Management grew 14% and 11% respectively.
Quick Commerce channel grew 70% YoY, contributing to a stronger organized trade mix of 32%.
International business was hit by geopolitical issues in the Middle East but saw a 2% recovery in April 2026.
Strategic investments grew 34% with a management target of 30% CAGR and improved EBITDA margins.
👀 What to Watch
Investors should hold for a recovery in FY27 as management guides for double-digit growth in summer categories and international markets. The significant margin expansion and growth in new-age brands suggest strong underlying business health despite seasonal setbacks.
Emami Q4FY26 Revenue Dips 4% to ₹925 Cr; Non-Summer Domestic Portfolio Grows 11%
Emami's Q4FY26 performance was impacted by a 22% decline in its summer portfolio and geopolitical disruptions in West Asia, leading to a 4% consolidated revenue drop to ₹925 crore. Despite these headwinds, the non-summer domestic business showed resilience with 11% growth, and gross margins expanded significantly by 250 bps to 68.4%. The company is aggressively pivoting toward new-age channels, which now contribute 32% of domestic sales, and has completed strategic acquisitions in Axiom Ayurveda and IncNut. For the full year FY26, the company reported a PAT of ₹775 crore and declared a total dividend of ₹10 per share.
Key Highlights
Consolidated Q4 revenue declined 4% to ₹925 crore, while EBITDA fell 15% to ₹187 crore.
Gross margins expanded by 250 bps in Q4 to 68.4% and by 130 bps for the full year FY26 to 69.9%.
Domestic non-summer portfolio grew by 11% with a 7% volume growth, offsetting seasonal weakness.
Organized and New Age channels now contribute 32% of domestic business, up from 12% in FY20.
Strategic acquisitions of Axiom Ayurveda (AloFrut) and IncNut (Vedix, SkinKraft) to bolster the wellness and BPC portfolio.
👀 What to Watch
Investors should monitor the recovery of the summer portfolio in Q1FY27 and the integration of new-age acquisitions. The strong margin expansion and shift toward organized trade channels are positive indicators for long-term profitability.
Emami Q4FY26: Revenue Down 4% to ₹925 Cr; Non-Summer Portfolio Grows 11%
Emami reported a challenging Q4FY26 with consolidated revenue declining 4% to ₹925 crore, primarily due to a 22% drop in its summer portfolio and geopolitical disruptions in West Asia. However, the core non-summer domestic business showed resilience with 11% growth, and gross margins expanded by 250 basis points to 68.4%. The company is strategically pivoting towards digital-first brands and organized channels, which now contribute 32% of domestic revenue. Strategic acquisitions in Axiom Ayurveda and IncNut are expected to bolster the health beverage and personalized beauty segments in FY27.
Key Highlights
Consolidated Revenue declined 4% YoY to ₹925 crore; EBITDA fell 15% to ₹187 crore.
Domestic non-summer portfolio grew 11% with 7% volume growth, offsetting seasonal headwinds.
Gross Margins expanded by 250 bps to 68.4% through cost management and pricing actions.
International business declined 5% due to West Asia shipping disruptions, despite 16% growth in Jan-Feb.
Strategic investments made to acquire majority stakes in Axiom Ayurveda (AloFrut) and IncNut (Vedix, SkinKraft).
👀 What to Watch
Investors should look past the seasonal volatility and focus on the strong 11% growth in the non-summer portfolio and significant margin expansion. Monitor the integration of new-age acquisitions and the recovery of the international business as geopolitical tensions stabilize.
Emami Approves FY26 Results and Re-appoints Harsha Vardhan Agarwal as MD for 5 Years
Emami Limited's Board of Directors met on May 21, 2026, to approve the audited financial results for the quarter and fiscal year ended March 31, 2026. The statutory auditors, S.R. Batliboi & Co. LLP, issued an unmodified opinion on these results, indicating no major accounting discrepancies. A key leadership decision was the re-appointment of Shri Harsha Vardhan Agarwal as Vice-Chairman & Managing Director for a five-year term starting April 2027. Additionally, the company scheduled its 43rd Annual General Meeting for August 25, 2026, and re-appointed its cost auditors for the next fiscal year.
Key Highlights
Approved audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.
Statutory Auditors S.R. Batliboi & Co. LLP issued an audit report with an unmodified opinion.
Re-appointed Harsha Vardhan Agarwal as Vice-Chairman & Managing Director for a 5-year term effective April 1, 2027.
Re-appointed M/s. V. K. Jain & Co, Cost Accountants, as Cost Auditors for the financial year 2026-27.
Scheduled the 43rd Annual General Meeting (AGM) of shareholders for August 25, 2026.
👀 What to Watch
Investors should examine the detailed financial results for growth trends and margin performance while noting the leadership stability provided by the MD's re-appointment. No immediate action is required beyond monitoring the upcoming AGM for further strategic updates.
Emami Re-appoints Harsha Vardhan Agarwal as MD for 5 Years; Approves FY26 Audited Results
Emami's Board has approved the re-appointment of Shri Harsha Vardhan Agarwal as Vice-Chairman and Managing Director for a five-year term effective April 1, 2027. The company also finalized its FY26 audited financial results, with statutory auditors issuing an unmodified opinion. Performance across subsidiaries was mixed, with one group reporting a revenue of ₹272.8 crore and a net loss of ₹12.4 crore, while another major subsidiary group contributed ₹385.18 crore in revenue with a net profit of ₹18.33 crore. The 43rd Annual General Meeting is scheduled for August 25, 2026, to ratify these decisions.
Key Highlights
Re-appointment of Harsha Vardhan Agarwal as MD for a 5-year term starting April 2027
Audited FY26 results approved with an unmodified auditor's opinion
Three subsidiaries reported combined FY26 revenue of ₹272.80 crore and a net loss of ₹12.40 crore
One major subsidiary group (including 6 sub-entities) reported FY26 revenue of ₹385.18 crore and profit of ₹18.33 crore
43rd AGM scheduled for August 25, 2026, to seek shareholder approval for management changes
👀 What to Watch
Investors should view the MD's re-appointment as a sign of leadership stability and continuity. While the core business remains stable, investors should monitor the performance of loss-making subsidiaries to ensure they do not drag down consolidated margins.
Emami Limited Executes Agreement to Acquire Stake in IncNut Digital Private Limited
Emami Limited has officially executed a Share Subscription and Purchase Agreement to acquire a stake in IncNut Digital Private Limited. This strategic move is aimed at strengthening Emami's presence in the digital-first and Direct-to-Consumer (D2C) beauty and wellness space. IncNut Digital is known for its personalized beauty brands like SkinKraft and Vedix. The acquisition aligns with Emami's long-term strategy to diversify its portfolio and engage with tech-savvy consumer segments.
Key Highlights
Execution of a formal Share Subscription and Purchase Agreement for stake acquisition in IncNut Digital.
Strategic entry into the personalized D2C beauty segment via brands like SkinKraft and Vedix.
The move follows the company's objective to scale its digital-first brand portfolio.
Compliance with SEBI (LODR) Regulations, 2015, for material event disclosure.
👀 What to Watch
Investors should view this as a positive step towards modernization; monitor the integration of IncNut's high-margin digital brands into Emami's traditional distribution network.
Emami Acquires 60% Stake in Vedix and SkinKraft for Rs 321 Crore
Emami Limited has entered into a definitive agreement to acquire a 60% majority stake in IncNut Digital, the parent company of personalized beauty brands Vedix and SkinKraft, for Rs 321 crore. The deal includes performance-linked adjustments over 24 months and a structured plan to acquire the remaining 40% stake within the next 4.5 years. This acquisition significantly strengthens Emami's presence in the high-growth, digital-first personalized Beauty and Personal Care (BPC) segment. It complements Emami's existing premium digital portfolio, which includes brands like The Man Company and Brillare.
Key Highlights
Acquisition of 60% stake in IncNut Digital for a consideration of Rs 321 crore
Full acquisition of the remaining 40% stake planned over the next 4.5 years in two tranches
Entry into the personalized BPC segment via flagship brands Vedix (Ayurveda) and SkinKraft (Dermatology)
Transaction includes performance-linked adjustments over a 24-month period to ensure valuation alignment
Strategic move to build a future-ready D2C portfolio and capture data-driven consumer demand
👀 What to Watch
Investors should view this as a positive long-term strategic move to modernize Emami's brand portfolio and tap into high-margin D2C segments. Monitor the integration progress and the impact of these high-growth brands on the company's consolidated revenue and margins.
Emami to Acquire 60% Stake in IncNut Digital (Vedix, SkinKraft) for ₹321 Crores
Emami Limited has entered into an agreement to acquire a 60% stake in IncNut Digital Private Limited, which operates personalized beauty brands Vedix and SkinKraft, for up to ₹321 crores. The acquisition is expected to close within 30 days, and Emami plans to acquire the remaining stake over the next 4.5 years based on performance milestones. While this move strengthens Emami's digital-first BPC portfolio, the target company has seen a declining revenue trend, falling from ₹231.9 Cr in FY23 to ₹175.1 Cr in FY25. This acquisition is a strategic attempt to capture the high-growth personalized personal care market.
Key Highlights
Acquisition of 60% stake in IncNut Digital for an aggregate consideration of up to ₹321 crores
Target company owns popular D2C personalized brands Vedix and SkinKraft
Full 100% acquisition planned within 4.5 years via two additional tranches
IncNut Digital's revenue has declined from ₹231.9 Cr (FY23) to ₹175.1 Cr (FY25)
Transaction expected to be completed within 30 days, making IncNut a subsidiary of Emami
👀 What to Watch
Investors should watch for Emami's ability to scale these digital brands and arrest the declining revenue trend of the target entity. The high valuation relative to current turnover suggests Emami is betting heavily on the turnaround and synergy potential of personalized BPC.
Emami Issues Corporate Guarantees Worth ₹176.24 Crore for Axiom Group Subsidiaries
Emami Limited has issued corporate guarantees totaling approximately ₹176.24 crore to HDFC Bank on behalf of its subsidiaries, Axiom Ayurveda, Axiom Foods & Beverages, and Axiom Packwell. This move follows Emami's acquisition of a 73.5% stake in Axiom Ayurveda in April 2026. The largest guarantee of ₹151.52 crore is for Axiom Foods & Beverages Pvt. Ltd. While these guarantees create a contingent liability, they facilitate necessary banking facilities for the subsidiaries' operations.
Key Highlights
Total corporate guarantee issued amounts to ₹17,623.68 Lakhs (approx ₹176.24 Crores)
Largest guarantee of ₹15,151.68 Lakhs provided to Axiom Foods & Beverages Pvt. Ltd.
Guarantees for Axiom Ayurveda and Axiom Packwell stand at ₹710 Lakhs and ₹1,762 Lakhs respectively
The action follows the acquisition of a 73.5% stake in Axiom Ayurveda on April 1, 2026
👀 What to Watch
Monitor the performance of the Axiom Ayurveda group to ensure they can service the debt, as these guarantees represent a contingent liability for Emami. No immediate action is required as this is a standard operational support for subsidiaries.
Emami to Acquire 100% Stake in Axiom Ayurveda (Alofrut) for up to Rs 200 Crore
Emami Limited has executed a definitive agreement to acquire the remaining 73.5% stake in Axiom Ayurveda, bringing its total ownership to 100%. The acquisition, valued at an aggregate consideration not exceeding Rs 200 crore, marks Emami's formal entry into the high-growth beverage and health juice segment. Axiom is a profitable entity projected to achieve a topline of approximately Rs 180 crore in FY26. The deal is expected to be completed in a phased manner over the next three months.
Key Highlights
Acquisition of remaining 73.5% stake in Axiom Ayurveda for a total consideration up to Rs 200 crore
Axiom Ayurveda is projected to reach a revenue of approximately Rs 180 crore by FY26
Marks Emami's formal entry into the beverage sector with brands like AloFrut and Axiom Jeevan Ras
Appointment of Harkirat Bedi, formerly of Dabur, as the new CEO of Axiom Ayurveda
The acquisition is expected to be fully completed within a 3-month timeline
👀 What to Watch
Investors should view this as a strategic diversification into the high-growth health and wellness beverage market. Monitor the integration of Axiom's portfolio and its contribution to Emami's consolidated margins in the coming fiscal year.
Emami Acquires Controlling Stake in Axiom Ayurveda; AAPL Becomes a Subsidiary
Emami Limited has entered into a Share Purchase Agreement to acquire the remaining 73.5% stake in its associate company, Axiom Ayurveda Private Limited (AAPL). On April 1, 2026, the company completed the first tranche by acquiring 84,30,909 shares (~36.7% stake), officially making AAPL a subsidiary. The final acquisition of the remaining 84,30,909 shares is expected to be completed by June 2026. This move allows Emami to fully consolidate and control the Ayurveda-focused brand.
Key Highlights
Acquisition of ~73.5% stake in Axiom Ayurveda Private Limited to achieve 100% ownership
First tranche of 84,30,909 equity shares (~36.7%) completed on April 1, 2026
Axiom Ayurveda has transitioned from an associate company to a subsidiary of Emami
Final acquisition of the remaining stake is scheduled for completion by June 2026
👀 What to Watch
Investors should view this consolidation as a positive step for Emami's Ayurveda portfolio expansion. Monitor the impact of this acquisition on the company's consolidated revenue and margins in the coming quarters.
